Last reviewed · How we verify
NCT07041944: HEMImprove-APP
HEMImprove 1.0 in Children and Adolescents With Unilateral Cerebral Palsy
NA trial testing HEMImprove APP in Unilateral Cerebral Palsy in 36 participants. Not yet recruiting.
1 February 2027
Quick facts
| Lead sponsor | University of Castilla-La Mancha |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 1 March 2026 |
| Primary completion | 1 February 2027 |
| Estimated completion | 1 December 2027 |
Drugs / interventions tested
- HEMImprove APP
- exercises to upper limb
Conditions studied
- Unilateral Cerebral Palsy — all drugs for Unilateral Cerebral Palsy →
Sponsor
University of Castilla-La Mancha
Who can join
Adults 12 to 18, any sex, with Unilateral Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effectiveness and usability of HEMImprove 1.0, a gamified mobile application designed to improve upper limb motor function in adolescents with unilateral cerebral palsy. Participants will be randomly assigned to an intervention group using the app or a control group performing conventional home exercises. The intervention will last four weeks, with assessments before and after the intervention to measure motor function, motivation, and quality of life improvements.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07041944
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Unilateral Cerebral Palsy
Currently open trials in the same condition.
- NCT06536634 — Effects and Mechanisms of Sensory Afferent Electrostimulation on Upper Limb Function in Patients With Hemiparesis · NA · recruiting
- NCT06872736 — Wereables for Upper Limb Functionality in Hemiparesis · Phase 2, PHASE3 · recruiting
Other University of Castilla-La Mancha trials
Trials by the same sponsor.
- NCT07487857 — Intensive Somatosensory Camp for Manual Function and Participation in Children With Unilateral Cerebral Palsy · NA · not yet recruiting
- NCT07419035 — Bipolar Radiofrequency for Genitourinary Syndrome of Menopause · NA · not yet recruiting
- NCT07452172 — Lumbar and Gluteal Motor Control in Chronic Low Back Pain · NA · not yet recruiting
- NCT07091461 — HOMe-IMprove Telerrehabilitation System · NA · not yet recruiting
- NCT07424534 — Predictive Models on Psychosocial Profile, Fatigue and Sleep Quality · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07041944 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Castilla-La Mancha
- Last refreshed: 18 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07041944.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing